Abstract
Transfusion of blood into patients awaiting renal transplantation did not require policy decisions during the early phase of the history of transplantation in the 1960s. Instead, blood transfusion was a clinical requirement for the successful dialysis of uraemic patients. Blood transfusion in the late 1980s and the 1990s has, by contrast, become a less frequently mandated therapy with the advent of efficient low-volume dialysers, reduced blood loss, alternative blood volume expanders and, finally, with erythropoietin. The hazards of blood transfusion have also, during those 20 years, become better appreciated. Every renal physician must therefore now have a policy on Mood transfusion, particularly for those patients who are awaiting either a cadaver or a living related kidney transplant. The span of 20 years of research and clinical experience has provided an enormous literature from which it is possible to find reference to the therapeutic advantage of almost any policy on blood transfusion. In this chapter, I will attempt to pick my way through that literature to highlight some of the evidence used to support the various current policies on blood transfusion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kissmeyer-Nielsen, F., Olsen, S., Petersen, V. P. and Fjeldborg, O. (1966). Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet, 1, 662–665
Dausset, J. (1955). Leuco-aggulutinins. IV. Leucoagglutinins and blood transfusions. Vox Sang, 4, 190–198
Patel, R. and Terasaki, P. I. (1969). Significance of the positive crossmatch test in kidney transplantation. N. Engl. J. Med., 280, 735–739
Michielsen, P. (1966). Hemodialyse at transplantation renale. Proc. Eur. Dial. Transplant. Assoc, 3, 162–164
Dossetor, J. B., MacKinnon, K.J., Gault, M.H. and MacLean, L.D. (1967). Cadaver kidney transplants. Transplantation, 5, 844–853.
Morris, P. J., Ting, A. and Stocker, J. (1968). Leukocyte antigens in renal transplantation. I The paradox of blood transfusions in renal transplantation. Med. J. Aust, 2, 1088–1090
Hume, D. I., Rapaport, F. T. and Dausset, J. (eds). Kidney Transplantation, p. 131. (New York: Grune and Stratton)
Opelz, G., Sengar, D.P.S., Mickey, M.R. and Terasaki, P.I. (1973). Effect of blood transfusions on subsequent kidney transplants. Transplant. Proc., 5, 253–259
Opelz, G. For the Collaborative transplant study (1987). Improved kidney graft survival in non-transfused recipients. Transplant. Proc., 19, 149–152
Van Rood, J. J. (1983). Pretransplant blood transfusion: sure! but how and why? (1983). Transplant. Proc., 15, 915–916
Opelz, G. (1984). Blood transfusion. In Morris, P.J. (ed.) Kidney Transplantation, Principles and Practice, Edn 2, pp. 323–334. (New York: Grune and Stratton)
Opelz, G. (1988). To transfuse or not before transplantation. In Morris, P.J. (ed.) Kidney Transplantation, Principles and Practice, Edn 3. (New York: Grune and Stratton)
Opelz, G. and Terasaki, P. I. (1978). Improvement of kidney-graft survival with increased numbers of blood transfusion. N. Engl. J. Med., 299, 799–803
Cecka, M. and Cicciarelli, J. (1985). The transfusion effect. In Terasaki, P.I. (ed.) Clinical Kidney Transplants, pp. 73–92 (UCLA: Tissue Typing Laboratory)
Persijn, G.G., Van Leeuwen, A., Parlevliet, J., Cohen, B., Lansbergen Q., D’Amaro, J. and Van Rood, J.J. (1981). Two major factors influencing kidney graft survival in Eurotransplant: HLA-DR matching and blood transfusions. Transplant. Proc., 13, 150–154
Fuller, T.C., Delmonico, F. L., Cosini, A.B., Huggins, G. E., King, M. and Russell, P. S. (1978). Impact of blood transfusion on renal transplantation. Ann. Surg., 187, 211–218
Batchelor, J. R., Welsh, K.I. and Burgos, H. (1977). Immunological enhancement. Transplant. Proc., 9, 931–936
Borleffs, J.C.C., Neuhaus, P., Van Rood, J.J. and Balner, H. (1982). Platelet transfusions improve kidney allograft survival in rhesus monkeys without inducing cytotoxic antibodies. Lancet, 1, 1117–1118
Oh, J.H., McClure, H.M. and Tuttle, E.P. (1983). Immunological unresponsiveness induced by platelet transfusion in rhesus monkeys. Transplantation, 36, 727–728
Errett, L.E., Allen, N., Deierhoi, M.H., Denton, T.G., Wood, R.F.M. and Morris, P. J. (1985). The effect of platelet transfusions on renal allograft survival and sensitisation in dogs. Tissue Antigens, 25, 28–32
Marquet, R. L., Tank, B., Jeineman, E., Obertop, H., Niessen, G.J. CM., Bignen, A.B., Westbroek, D. L. and Jeekel, J. (1983). Pre-transplant platelet transfusions do not improve kidney graft survival in beagle dogs. Lancet, 1, 774
Chapman, J. R., Ting, A., Fisher, M., Carter, N.P. and Morris, P.J. (1986). Failure of platelet transfusion to improve human renal allograft survival. Transplantation, 41, 468–473
Pallardo, L.N., Montoro, J., Moll, J. L., Sanchez, J., Soler, M. A., Marty, M. and Cruz, J.N. (1985). Platelet transfusions do not improve cadaveric renal allograft survival. Transplant. Proc., 17, 2338–2339
Betuel, H., Cantarovitch, D., Robert, F., Gebuher, L., Touraine, J. L., Dubernard, J.N. and Traeger, J. (1985). Platelet transfusions preparative for kidney transplantation. Transplant. Proc., 17, 2335–2337
Norman, D. J., Barry, J. N., Durr, M. and Wetesteon, P. (1985). A preliminary analysis of a randomised study of buffy coat transfusions in renal transplantation. Transplant. Proc., 17, 2330–2332
Okazaki, H., Takahashi, H., Miura, K., Makoto, I. and Taguchi, Y. (1984). Significant reduction of sensitisation and improved allograft outcome with donor specific buffy coat transfusions. Transplantation, 37, 523–525
Ferrara, G. B., Tosi, R. N., Azzolina, G., Carminati, G. and Longo, A. (1974). HL-A unresponsiveness induced by weekly transfusions of small aliquots of whole blood. Transplantation, 17, 194–200
Müller, J. Y., Kaplan, C., Betuel, H., Bignon, J. D., Fauchet, R., Gluckman, J. C., Soulillou, J. P. and Thibault, Ph. (1982). Effet des transfusions sanguines sur les graffes de vein. Nouv. Presse Med., 11, 3697–3701
Stiller, C. R., Lockwood, B. L. and Sinclair, N. R. (1978). Beneficial effect of operation-day blood-transfusions on human allograft survival. Lancet, 1, 169–170
Williams, K. A., Ting, A., French, M. E., Oliver, D. and Morris, P. J. (1980). Peroperative blood-transfusions improve cadaveric renal-allograft survival in non-transfused recipients. Lancet, 1, 1104–1106
Sanfilippo, F., Spees, E. K. and Vaughn, W. K. (1984). The timing of pre-transplant transfusions and renal allograft survival. Transplantation, 37, 344–350
Heineman, E., Marquet, R. L., Heystek, G. A., Cobussen, A. and Jeekel, J. (1983). Modification of allograft rejection in rates by blood transfusions to the donor. Transplant. Proc., 15, 994–996
Jeekel, J., Harder, F., Persijn, G. G., Brynger, H. and Marquet, R. L. (1983). Beneficial effect of blood transfusion to the donor on kidney graft survival in man: a study in three centers. Transplant. Proc., 15, 973–975
Frisk, B., Berglin, E. and Brynger, H. (1983). Transfused cadaver kidney donors and graft survival. Transplantation, 35, 352
Cecka, M. and Terasaki, P. I. (1987). Improvement of kidney transplant regraft results by using trauma death donors. Transplantation, 44, 792–795
Voronoy, Y. Y. (1936). Sobre el bloque del aparato reticloendothelial del hombre en alaqunas formes de intoxicacion por el sublimado y sobre la transplantation del rinon cadaverico como metodo de tratamiento de la anuria consecutiva a aquella intoxicacion. Siglo. Med., 97, 296
Rubin, R. H., Jenkins, R. L., Shaw, B. W., Shaffer, D., Pearl, R. H., Erb, S., Nonaco, A. P. and van Thiel, D. H. (1987). The acquired immunodeficiency syndrome and transplantation. Transplantation, 44, 1–4
Melzer, J. S., Husing, R. M., Feduska, N. J., Tomlanovich, S. J., Vincenti, F., Amend, W. J. C., Garovoy, M. and Salvatierra, O. (1987). The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients. Transplantation, 43, 61–64
Dausset, J., Nenna, A. and Brecy, A. (1954). Leukoagglutinins, V. Blood, 9, 696–720
Opelz, G., Mickey, M.R. and Terasaki, P.I. (1981). Blood transfusions and kidney transplants: remaining controversies. Transplant. Proc., 13, 136–141
Opelz, G., Graver, B., Mickey, R. and Terasaki, P. I. (1981). Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation, 32, 177–183
Scornik, J. C., Ireland, J. E., Howard, R. J. and Pfaff, W. W. (1987). Assessment of the risk for broad sensitization by blood transfusions. Transplantation, 37, 249–253
Scornik, J. C., Ireland, J. E., Salomon, D. R., Howard, R. J., Fennell, R. S. and Pfaff, W. W. (1987). Pretransplant blood transfusions in patients with previous pregnancies. Transplantation, 43, 449–450
Sanfilippo, F., Vaughn, W. K., Bollinger, R. R. and Spees, E.K. (1984). The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. Transplantation, 37, 350–356
Rafftery, M. J., Lang, C. J., Schwarz, G., O’Shea, J., Varghese, Z., Sweny, P., Fernando, O. N. and Moorhead, J. F. (1985). Failure of azathropine to prevent sensitization due to third-party transfusion. Transplant. Proc., 17, 1044–1046
Cardella, C. J., Falk, J. A., Peters, P., Nicholson, J. and Harding, N. (1982). Do repeated blood transfusions prevent successful transplantation in highly sensitized potential transplant recipients? Transplant. Proc., 14, 359–60
Norman, D. J., Barry, J. M., Boehne, C. and Wetzsteon, P. (1985). Natural history of patients who make cytotoxic antibodies following prospective fresh blood transfusions. Transplant. Proc., 17, 1041–1043
Sanfilippo, F., Vaughn, W.K., Bollinger, R. R. and Spees, E. K. (1982). Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation, 34, 360–366
Chapman, J. R., Taylor, C. J., Ting, A. and Morris, P.J. (1986). Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Transplantation, 42, 608–613
Sanfilippo, F., Goeken, N., Niblack, G., Scornik, J. and Vaughn, W. K. (1987). The effect of first cadaver renal transplant HLA-A,B match on sensitization levels and retransplant rates following graft failure. Transplantation, 43, 240–244
Chapman, J. R. (1986). Humoral sensitisation of potential renal transplant recipients. M.D. Thesis. Cambridge University
Scornik, J. C., Ireland, J. E., Howard, R. J., Pfaff, W. W. and Fennell, R. S. (1983). Sensitization by blood transfusion in previously transplanted patients. Transplantation, 35, 505–506
Lundgren, G., Groth, C. G., Albrechtsen, D., Brynger, H., Flatmark, A., Frodin, L., Gabel, H., Husberg, B., Klintmalm, G., Maurer, W., Persson, H., and Thorsby, E. (1986). HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation — a changing picture with cyclosporin. Lancet, 2, 66–69
Opelz, G. (1987). Improved kidney graft survival in nontransfused recipients. Transplant. Proc., 19, 149–152
Groth, C. G. (1987). There is no need to give blood transfusions as pretreatment for renal transplantation in the cyclosporine era. Transplant. Proc., 19, 153–154
Terasaki, P. I., Himaya, N.S., Cecka, M., Cicciarelli, J., Cook, D.J., Ito, T., Iwaki, Y., Mickey, R., Takiff, H., Tiwari, J. L. and Toyotome, A. (1986). spivn In Terasaki, P. I. (ed.) Clinical Transplants 1986, pp. 367–92. (Los Angeles: UCLA Tissue Typing Laboratory)
Newton, W. T. and Anderson, C. B. (1973). Planned pre-immunization of renal allograft recipients. Surgery, 74, 430
Salvatierra, O., Vincenti, F., Amend, W., Potter, D., Iwaki, Y., Opelz, G., Terasaki, P., Duca, R., Cochrum, K., Hanes, D., Stoney, R.J. and Feduska, N.J. (1980). Deliberate donor specific blood transfusions prior to living related renal transplantation. Ann. Surg., 192, 543–552
Glass, N. R., Miller, D. T., Sollinger, H. W. and Beizer, F. O. (1983). Comparative analysis of the DST and Imuran-plus-DST protocols for live donor renal transplantation. Transplantation, 36, 636–641
Colombe, B. W., Lou, D. D., Salvatierra, O. and Garavoy, M. R. (1987). Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Transplantation, 44, 509–515
Vaidya, S., Sommer, B.G., Pagel, E., Koegel, M. and Ferguson, R. M. (1986). Assessment of factors associated with donor-specific sensitization in patients given donor-specific blood transfusions. Transplantation, 42, 695–697.
Salvatierra, O., Melzer, J., Potter, D., Garavoy, M., Vincenti, F., Amend, W. J. C., Husing, R., Hopper, S. and Feduska, N. J. (1985). A seven-year experience with donor-specific blood transfusions. Transplantation, 40, 654–659
Okazaki, H., Takahashi, H., Oguma, S., Jimbo, M. and Ishizaki, M. (1987). Transplant outcome of desensitised recipients after donor specific transfusion. Transplant. Proc., 19, 750–752
Whelchel, J. D., Shaw, J. F., Curtis, J. J., Luke, R.G. and Diethelm, A.G. (1982). Effect of pretransplant stored donor-specific blood transfusions on early renal allograft survival in one-haplotype living related transplants. Transplantation, 34, 326–329
Cheigh, J. S., Suthanthiran, M., Kaplan, M., Evelyn, M., Riggio, R. R., Fotino, M., Schechter, N., Wolf, C. F. W., Stubenbord, W. T., Stenzel, K. H. and Rubin, A. L. (1984). Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion. Transplantation, 38, 501–506
Schweizer, R. T., Bartus, S. A., Rorelli, M. A. and Bow, L. M. (1986). Use of two donor-specific transfusions for living-related donor kidney transplantation. Transplantation, 42, 562–564
Flechner, S. N., Kerman, R. H., Van Buren, C. and Kahan, B. D. (1984). Successful transplantation of cyclosporin-treated haploidentical living-related renal recipients without blood transfusions. Transplantation, 37, 73–76
Albrechtsen, D., Flatmark, A., Lundgren, G., Brynger, H., Frodin, L., Groth, C. G., Gabel, H. and Thorsby, E. (1987). Renal transplantation from HLA-haploidentical living related donors: The Scandinavian multicenter study of the effects of cyclosporin immunosuppression. Clin. Transplant., 1, 104–107
Opelz, G. (1985). Comparison of random transfusions with donor-specific transfusions for pretreatment of HLA One-haplotype-matched related donor kidney transplant recipients. Transplant. Proc., 17, 2357–2361
Iwaki, Y. and Terasaki, P.I. (1986). Donor specific transfusion. In Terasaki, P. I. (ed.) Clinical Transplants 1986, pp. 267–275. (Los Angeles: UCLA Tissue Typing Laboratory)
Burlingham, W.J., Grailer, A., Sparks-Mackety, E.N. F., Sondel, P.M. and Sollinger, H.W. (1987). Improved renal allograft survival following donor-specific transfusions. Transplantation, 43, 41–46
Bakran, A., Taylor, G. M., Read, I., Fergusson, W. and Johnson, R. W. G. (1987). Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation. Transplant. Proc., 19, 748–749
MacLeod, A. M., Mason, R. J., Stewart, K. N., Power, D. A., Shewan, W. G., Edward, N. and Catto, G. R. D. (1982). Association of Fc receptor-blocking antibodies and human renal transplant survival. Transplantation, 34, 273–279
MacLeod, A. M., Hillis, A. N., Mather, A., Bone, J. N. and Catto, G. R. D. (1987). Effect of cyclosporin, previous third-party transfusion, and pregnancy on antibody development after donor-specific transfusion before renal transplantation. Lancet, 1, 416–418
Singal, D. P., Fagnilli, L. and Joseph, S. (1983). Blood transfusions induce antiidiotype antibodies in renal transplant patients. Transplant. Proc., 15, 1005–1008
Reed, E., Hardy, M., Benvenisty, A., Lattes, C., Brensilver, J., McCabe, R., Reemsta, K., King, D. W. and Suciu-Foca, N. (1987). Effect of anti-idiotypic antibodies to HLA on graft survival in renal allograft recipients. N. Engl. J. Med., 316, 1450–1455
Toma, H., Hayasaka, Y., Yasuo, N., Takahashi, K., Teraoka S. and Ota, K. (1987). Anti-idiotypic autoantibodies after donor-specific blood transfusions. Transplant. Proc., 19, 755–757
Hutchinson, I. V. (1986). Suppressor T cells in allogeneic models. Transplantation, 41, 547–555
Leivestad, T. and Thorsby, E. (1984). Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness. Transplantation, 37, 175–181
Billingham, R. E., Brent, L. and Medawar, P. B. (1953). Actively acquired tolerance of foreign cells. Nature (London), 172, 603–606
Medawar, P. B. (1963). The use of antigenic tissue extracts to weaken the immunological reaction against skin homografts in mice. Transplantation, 1, 21–57
Fabre, J. W. and Morris, P. J. (1972). The effect of donor strain blood pre-treatment on renal allograft rejection in rats. Transplantation, 14, 608–617
Van der Linden, C. J., Burman, W. A., Vegt, P.A., Greep, J. M. and Jeekel, J. (1982). Effect of blood transfusions on canine renal allograft survival. Transplantation, 33, 400–402
Van Es, A. A., Marquet, R. L., Van Rood, J. J. and Balmer, H. (1978). Influence of a single blood transfusion in unrelated rhesus monkeys. Transplantation, 26, 325–330
Wood, K. J., Evins, J. and Morris, P. J. (1985). Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. Transplantation, 39, 56–62
Lauchart, W., Alkins, B. J. and Davies, D. A. L. (1980). Only B lymphocytes induce active enhancement of rat cardiac allografts. Transplantation, 29, 259–261
Spencer, S. C. and Fabre, J. (1987). Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex antigen from DA rat liver, and studies of specific immunosuppression. Transplantation, 44, 141–148
Everett, S. T., Kao, K-J. and Scornik, J. C. (1987). Class I HLA molecules on human erythrocytes. Transplantation, 44, 123–129
Madsen, J. C., Superina, R. A., Wood, K. J. and Morris, P. J. (1988). Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature (London), 332, 161–164
Quigley, R. L., Wood, K. J. and Morris, P. J. (1988). Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion. Immunology, 63, 373–381
Johnson, C. P., Munda, R., Alexander, J. W., Balakrishnan, K. and Blanton, M. (1984). The effect of donor-specific transfusions on rat heart allograft survival. Transplantation, 38, 575–578
Ludwin, D., Joseph, S. and Singal, D. P. (1986). MLC-Inhibiting antibodies in mice after blood transfusions. Transplantation, 41, 100–104
Opelz, G., Graver, B. and Terasaki, P. I. (1981). Induction of high kidney graft survival rate by multiple transfusion. Lancet, 1, 1223–1225
Feduska, N. J., Vincenti, F., Amend, W. J., Duca, R., Cochrum, K. and Salvatierra, O. (1979). Do blood transfusions enhance the possibility of a compatible transplant? Transplantation, 27, 35–38
Blumberg, N., Heal, J. M., Murphy, P., Agarwal, M. M. and Chuang, C. (1986). Association between transfusion of whole blood and recurrence of cancer. Br. Med. J., 293, 530–533
Mowbray, J. F., Gibbings, C. R., Sidgwick, A. S., Ruszkiewicz, M. and Beard, R. W. (1983). Effects of transfusion in women with recurrent spontaneous abortion. Transplant. Proc., 15, 896–899
Forwell, M. A., Cocker, J. E., Peel, M. G., Tsakiris, D. J., Briggs, J. D., Junor, B. J. R., MacSween, R. N. M. and Sandilands, G. P. (1987). Correlation between high-molecular-weight Fcy-receptor-blocking factors in serum and renal allograft survival. Transplantation, 44, 227–233
Macleod, A. M., Power, D. A., Mason, R. J., Stewart, K. N., Shewan, W. G., Edward, N. and Catto, G. R. (1982). Possible mechanism of action of transfusion effect in renal transplantation. Lancet, 2, 468–470
Macleod, A. M., Stewart, K. N., Mather, A., Engeset, J., Edward, N. and Catto, G. R. D. (1987). Noncytotoxic antibodies and renal transplant outcome. Transplantation, 44, 840–842
Suzuki, S., Mizuochi, I., Sada, M. and Ameoniya, H. (1985). Transplantation tolerance mediated by suppressor T cells and suppressive antibody in a recipient of a renal transplant. Transplantation, 40, 357–363
Charpentier, B. M., Bach, M. A., Lang, P. and Fries, D. (1983). Expression of OKT8 antigen and Fcr receptors by suppressor cells mediating specific unresponsiveness between recipient and donor in renal-allograft-tolerant patients. Transplantation, 36, 495–501
Woodruff, M. F. A. and van Rood, J. J. (1983). Possible implications of the effect of blood transfusion on allograft survival. Lancet, 1, 1201–1203
Barkley, S. C., Sakai, R. S., Ettenger, R. B., Fine, R. N. and Jordan, S. C. (1987). Determination of anti-idiotypic antibodies to anti-HLA IgG following blood transfusions. Transplantation, 44, 30–34
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Chapman, J.R. (1989). Blood Transfusion Policy. In: Catto, G.R.D. (eds) Transplantation. New Clinical Applications Nephrology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0855-0_1
Download citation
DOI: https://doi.org/10.1007/978-94-009-0855-0_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6872-7
Online ISBN: 978-94-009-0855-0
eBook Packages: Springer Book Archive